Jaguar Health Inc [NASDAQ: JAGX] jumped around 0.01 points on Friday, while shares priced at $0.18 at the close of the session, up 5.88%. Compared to the average trading volume of 61.31M shares, JAGX reached a trading volume of 43322322 in the most recent trading
Jaguar Health Inc [NASDAQ: JAGX] loss -11.41% or -0.02 points to close at $0.16 with a heavy trading volume of 30588986 shares. The daily chart for JAGX points out that the company has recorded -54.10% loss over the past six months. If we look at
Jaguar Health Inc [NASDAQ: JAGX] loss -16.00% or -0.02 points to close at $0.09 with a heavy trading volume of 26628065 shares. The daily chart for JAGX points out that the company has recorded -62.69% loss over the past six months. If we look at
Jaguar Health Inc [NASDAQ: JAGX] stock went on an upward path that rose over 8.53% on Friday, amounting to a one-week price decrease of less than -6.56%. The company report on April 2, 2024 at 8:50 AM that Jaguar Health Appoints European Pharmaceutical Industry Leader
Jaguar Health Inc [NASDAQ: JAGX] closed the trading session at $0.09. The company report on March 27, 2024 at 8:30 AM that Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates. Click here to
Jaguar Health Inc [NASDAQ: JAGX] surged by $0.0 during the normal trading session on while it closed the day at $0.07. The company report on March 20, 2024 at 8:30 AM that GEN to Commercialize Jaguar Health’s Crofelemer in Turkey and Eight Neighboring Countries and
Jaguar Health Inc [NASDAQ: JAGX] traded at a low on Friday, posting a -8.99 loss after which it closed the day’ session at $0.07. The company report on March 20, 2024 at 8:30 AM that GEN to Commercialize Jaguar Health’s Crofelemer in Turkey and Eight
Jaguar Health Inc [NASDAQ: JAGX] loss -6.79% or -0.01 points to close at $0.07 with a heavy trading volume of 28935123 shares. The company report on February 23, 2024 at 8:30 AM that Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance. Jaguar Health,
Jaguar Health Inc [NASDAQ: JAGX] loss -0.24% or 0.0 points to close at $0.08 with a heavy trading volume of 20050871 shares. The company report on February 23, 2024 at 8:30 AM that Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance. Jaguar Health,
Jaguar Health Inc [NASDAQ: JAGX] jumped around 0.03 points on Friday, while shares priced at $0.09 at the close of the session, up 50.00%. The company report on February 23, 2024 at 8:30 AM that Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance.
© 2024, Powered by Smart TechOne
